Portfolio company
Augment Biologics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops a glycoengineering platform for designing therapeutic proteins with specific sugar patterns for pharmaceutical manufacturers and biotechnology research teams.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Kyron.bio
This company develops glycan-engineering technology to improve therapeutic proteins and antibodies for pharmaceutical firms and research institutions.
Dogma Biotech
This company develops AI-designed glycans to enhance protein therapeutic performance for patients with central nervous system and lysosomal storage diseases.
Silicozyme
This company develops enzymatic toolkits and bioprocessing technologies for protein manufacturing and biologics production for industrial biotechnology and pharmaceutical customers.
53Biologics
This company provides contract development and manufacturing services for recombinant proteins and plasmid DNA to biotechnology and pharmaceutical firms.
Cellagenics
This biotechnology firm develops technology to enhance therapeutic antibody and protein production in mammalian cell lines for biopharmaceutical manufacturers.
Aikium
This company develops artificial intelligence and synthetic biology platforms to design and screen protein therapeutic libraries for biotechnology and pharmaceutical partners.
Glyphic
This biotechnology company develops a protein sequencing platform for researchers to accelerate drug discovery and proteomic analysis.
Protillion Biosciences
This company develops a high-throughput protein engineering platform for pharmaceutical partners to accelerate the discovery and optimisation of therapeutic antibodies and binder drugs.
